These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18007096)

  • 1. [H.pylori in patients with cirrhosis and liver cirrhosis with hepatocellular carcinoma].
    Xu MH; Qu Q; Zhang GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):917-20. PubMed ID: 18007096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma.
    Leone N; Pellicano R; Brunello F; Cutufia MA; Berrutti M; Fagoonee S; Rizzetto M; Ponzetto A
    Cancer Detect Prev; 2003; 27(6):494-7. PubMed ID: 14642558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?
    Ponzetto A; Pellicano R; Leone N; Cutufia MA; Turrini F; Grigioni WF; D'Errico A; Mortimer P; Rizzetto M; Silengo L
    Med Hypotheses; 2000 Feb; 54(2):275-7. PubMed ID: 10790764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated?
    Wu XZ; Chen D
    J Gastroenterol Hepatol; 2006 Feb; 21(2):345-7. PubMed ID: 16509857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
    Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
    Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of HBV, HCV and HDV serum markers in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC)].
    Zeng WZ; Chu RJ; Jiang MD
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):167-9. PubMed ID: 8222980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma.
    Rocha M; Avenaud P; Ménard A; Le Bail B; Balabaud C; Bioulac-Sage P; de Magalhães Queiroz DM; Mégraud F
    Gut; 2005 Mar; 54(3):396-401. PubMed ID: 15710989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
    Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.
    Pellicano R; Mazzaferro V; Grigioni WF; Cutufia MA; Fagoonee S; Silengo L; Rizzetto M; Ponzetto A
    World J Gastroenterol; 2004 Feb; 10(4):598-601. PubMed ID: 14966925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
    Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
    Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on Helicobacter infection in liver tissue from hepatocellular carcinoma].
    Li N; Zhang SH; Xuan SY; Qiang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):894-6. PubMed ID: 17343186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.